Royal Jubilee one of two BC hospitals offering new treatment for late-stage prostate cancer
Pluvicto is the newest innovation in treating late-stage prostate cancer—and could provide a blueprint for treating other cancers someday.
Pluvicto is the newest innovation in treating late-stage prostate cancer—and could provide a blueprint for treating other cancers someday.
CMI Weihai, a Chinese state-owned shipyard, was awarded the contract for four vessels after no Canadian companies submitted a bid.